Marcel Moulaison
Chief Tech/Sci/R&D Officer presso IRONWOOD PHARMACEUTICALS, INC.
Posizioni attive di Marcel Moulaison
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2019 | - |
| Corporate Officer/Principal | 01/01/2014 | 01/02/2019 |
Storia della carriera di Marcel Moulaison
Precedenti posizioni note di Marcel Moulaison
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01/01/2011 | 01/01/2014 |
Formazione di Marcel Moulaison
| Dalhousie University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Borsa valori
- Insiders
- Marcel Moulaison
- Esperienza
